Further studies on the erythrocyte uptake of lead in vitro in amyotrophic lateral sclerosis (ALS) patients and controls. Abnormal erythrocyte fragility in ALS.


Following our earlier observations on increased plasma concentrations of lead in amyotrophic lateral sclerosis (ALS), the erythrocyte uptake of lead from plasma has been studied in vitro. Whole-blood from ALS patients and controls was incubated after the addition of lead (0.6 mumol/l whole-blood) and plasma lead concentrations were repeatedly determined… (More)